Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-02-02 @ 11:26 AM
Study NCT ID:
NCT01352520
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-15
First Post:
2011-05-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma | View |
| None | Lymphoma, Primary Cutaneous Anaplastic Large Cell | View |
| None | Lymphomatoid Papulosis | View |
| None | Mycosis Fungoides | View |
| None | Skin Lymphoma | View |
| None | Cutaneous Lymphomas | View |
| None | Lymphoma | View |
| None | Hematologic Disorder | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | systemic therapy | View |
| None | cutaneous anaplastic large T cell lymphoma | View |
| None | ALCL | View |
| None | lymphomatoid papulosis | View |
| None | LyP | View |
| None | mycosis fungoides | View |
| None | MF | View |
| None | SGN-35 (brentuximab vedotin) | View |
| None | skin lymphomas | View |
| None | CD30-positive lymphoproliferative disorders | View |
| None | tumor lymphocytes | View |
| None | cutaneous lymphomas | View |
| None | CD30+ expression | View |
| None | Hematologic Disorder | View |
| None | Lymphoma | View |